Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Gaffney

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
Photochemistry and Photobiology|November 1, 1991
Cholesterol content but not plasma membrane fluidity influences the susceptibility of L1210 leukemia cells to merocyanine 540-sensitized irradiationD K Gaffney, J B Feix, H P Schwarz, et al.
Brachytherapy|August 8, 2007
An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancerBrandon M Barney, O Kenneth MacDonald, Christopher M Lee, et al.
Journal of Physical Activity & Health|May 21, 2019
The Implementation of a National Physical Activity Intervention in ColombiaLukas K Gaffney, Oscar D Lozano, Adriana Almanza, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapyD K Gaffney, J Holden, M Davis, et al.
Journal of Emergency Management (Weston, Mass.)|October 31, 2025
From national diversity to global synergy: Comparative lessons and recommendations for global actionWael ElRayes, Theodore J Cieslak, David Palm, et al.
Leukemia & Lymphoma|June 24, 2022
Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional studyMatthew W Parsons, David A Wada, Ahmad S Halwani, et al.
American Journal of Clinical Oncology|August 7, 2010
Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?Marcus A Crosby, Jonathan D Tward, Aniko Szabo, et al.
Rheumatology (Oxford, England)|September 11, 2008
Switching anti-TNF therapy in ankylosing spondylitisD J Pradeep, A C Keat, K Gaffney, et al.
Cancer|May 19, 2006
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphomaJonathan D Tward, Merideth M M Wendland, Dennis C Shrieve, et al.
American Journal of Clinical Oncology|October 9, 2019
Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?Dustin Boothe, Andrew Orton, Jaewhan Kim, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
Photochemistry and Photobiology|November 1, 1991
Cholesterol content but not plasma membrane fluidity influences the susceptibility of L1210 leukemia cells to merocyanine 540-sensitized irradiationD K Gaffney, J B Feix, H P Schwarz, et al.
Brachytherapy|August 8, 2007
An analysis of simulation for adjuvant intracavitary high-dose-rate brachytherapy in early-stage endometrial cancerBrandon M Barney, O Kenneth MacDonald, Christopher M Lee, et al.
Journal of Physical Activity & Health|May 21, 2019
The Implementation of a National Physical Activity Intervention in ColombiaLukas K Gaffney, Oscar D Lozano, Adriana Almanza, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2001
Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapyD K Gaffney, J Holden, M Davis, et al.
Journal of Emergency Management (Weston, Mass.)|October 31, 2025
From national diversity to global synergy: Comparative lessons and recommendations for global actionWael ElRayes, Theodore J Cieslak, David Palm, et al.
Leukemia & Lymphoma|June 24, 2022
Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional studyMatthew W Parsons, David A Wada, Ahmad S Halwani, et al.
American Journal of Clinical Oncology|August 7, 2010
Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?Marcus A Crosby, Jonathan D Tward, Aniko Szabo, et al.
Rheumatology (Oxford, England)|September 11, 2008
Switching anti-TNF therapy in ankylosing spondylitisD J Pradeep, A C Keat, K Gaffney, et al.
Cancer|May 19, 2006
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphomaJonathan D Tward, Merideth M M Wendland, Dennis C Shrieve, et al.
American Journal of Clinical Oncology|October 9, 2019
Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?Dustin Boothe, Andrew Orton, Jaewhan Kim, et al.
Pageof 29